Release Date: 01/10/21 09:18 Summary: Corporate Governance Statement 2021 Price Sensitive: No Download Document 226.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%